逆向腺/A2A受体信号传递促进了激发性突触传输和发作
Kaoutsar Nasrallah1, Coralie Berthoux1, Yuki Hashimotodani1
1Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Cell reports
|June 21, 2024
概括
通过A2A受体传递腺素信号,介导海马体的长期突触变化. 这一途径涉及来自大脑的神经营养因子 (BDNF) /TrkB信号传输,影响神经元可塑性,记忆力和.
科学领域:
- 神经科学是一个神经科学.
- 突触性可塑性 突触性可塑性
- 分子信号传输的方法
背景情况:
- 反向信号对神经元通信和突触可塑性至关重要.
- 通过逆行信号释放的神经递质释放的长期变化背后的机制尚未完全理解.
研究的目的:
- 为了确定负责任的逆行信号通路,在海马体中预突触长期增强 (LTP).
- 调查这种途径在记忆和中的作用.
主要方法:
- 在海马切片中的电生理学记录.
- 从特定的神经元群体中去除A2A受体或TrkB的基因操纵.
- 扣押诱导模型. 扣押诱导模型.
主要成果:
- 作用于A2A受体的腺素被确定为前突触LTP的关键逆行信号.
- 这种LTP依赖于来自大脑的神经营养因子 (BDNF) /热胺受体激酶B (TrkB) 信号传输.
- 腺素的释放是由后突触TrkB激活触发的.
- 阻断牙状回形中的A2A受体或TrkB显示出抗作用.
结论:
- 腺素/A2A受体信号传递在海马体中介导了前突触LTP.
- 这一途径可能会影响学习和记忆过程.
- 已识别的途径在促进活动中起作用.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
319
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
319
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Excitatory and Inhibitory Effects of Neurotransmitters
9.9K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.9K
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K


